ArticleClinical parkinsonism & related disorders2026
Refractory gastrointestinal symptoms improved with transition to continuous subcutaneous Foslevodopa/Foscarbidopa infusion in advanced Parkinson's disease.
Hanouf Aljuaid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.